World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, Scholar Article Journal Index (SAJI), International Scientific Indexing ( ISI ), 



*Muhammad Talha Tahir, Muhammad Bilal Mushtaq and Sadia Batool


Objective: To determine the frequency of pulmonary HTN in cases having COPD. Methodology: This was a cross-sectional study that was carried out at Department of Pulmonology, Sheikh Zayed Hospital, Rahim Yar Khan during November 2017 to May 2018. In this study the diagnosed cases of COPD of either gender and age more than 30 years irrespective of its aetiology and severity were selected according to grades of COPD GOLD criteria. The Pulmonary HTN was labelled as yes when resting pulmonary artery pressure (PAP) was more than 25 mmHg. Results: In this there were total 100 cases with mean age of 63.67±9.34 years. There were 86 (86%) males and 14 (14%) were females. Pulmonary HTN was seen in 37 (37%) of the cases. There was no significant difference in terms of gender in both groups with p= 0.74. Pulmonary HTN was significantly high in cases that had COPD duration of more than 24 months where it was seen in 34 (44.73%) cases with p= 0.01. It was also significantly high in cases with severe and very severe disease affecting 28 (41.17%) and 7 (38.89%) cases with p value of 0.03. Conclusion: Pulmonary HTN is seen in nearly every 3rd cases and it is observed significantly high in cases that had severe and very severe disease and also those with duration of disease for more than 24 months.

[Full Text Article]


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here